METASTATIC NEUROENDOCRINE NEOPLASM
Clinical trials for METASTATIC NEUROENDOCRINE NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new METASTATIC NEUROENDOCRINE NEOPLASM trials appear
Sign up with your email to follow new studies for METASTATIC NEUROENDOCRINE NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Triple-Drug cocktail shows promise against Tough-to-Treat neuroendocrine tumors
Disease control OngoingThis study tested a combination of three drugs—cabozantinib (which blocks cancer cell growth), nivolumab, and ipilimumab (which help the immune system attack cancer)—in 17 people with a rare, fast-growing type of neuroendocrine cancer that had spread. The goal was to see if the c…
Matched conditions: METASTATIC NEUROENDOCRINE NEOPLASM
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 12:09 UTC
-
Heart-Saving hope for neuroendocrine cancer patients in new drug trial
Disease control OngoingThis study tests whether adding telotristat ethyl to standard therapy can help prevent or control heart damage caused by carcinoid syndrome in people with advanced neuroendocrine tumors. About 79 adults whose cancer has spread and who are already on stable somatostatin analog the…
Matched conditions: METASTATIC NEUROENDOCRINE NEOPLASM
Phase: PHASE3 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 12:00 UTC